<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="367122">
  <stage>Registered</stage>
  <submitdate>19/09/2014</submitdate>
  <approvaldate>29/09/2014</approvaldate>
  <actrnumber>ACTRN12614001045606</actrnumber>
  <trial_identification>
    <studytitle>How androgens exert their anabolic effects: effects of oral testosterone on protein metabolism in healthy men.</studytitle>
    <scientifictitle>How androgens exert their anabolic effects. 
Effects of oral testosterone on protein metabolism in healthy men.</scientifictitle>
    <utrn>U1111-1161-9688 </utrn>
    <trialacronym>Oral testosterone study</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Protein metabolism in healthy men</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Normal metabolism and endocrine development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Oral micronised testosterone 40 mg daily for 14 days.
Adherence to treatment will be monitored by drug return.
</interventions>
    <comparator>Nil</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Protein turnover by using stable isotopes (leucine)</outcome>
      <timepoint>2 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy men</inclusivecriteria>
    <inclusiveminage>60</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Endocrine disorders</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>na</concealment>
    <sequence>na</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>Anova.
Sample size has been derived from previously published studies in hypogonadal men and postmenopausal women, where similar dose of oral testosterone significantly modified protein turnover.
Extrapolating from these studies with power of 80% a sample size of at least 8 will give p&lt;0.05.</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/10/2014</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>8</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Blacktown Hospital - Blacktown</hospital>
    <postcode>2148 - Blacktown</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other Collaborative groups</primarysponsortype>
    <primarysponsorname>Garvan Institute</primarysponsorname>
    <primarysponsoraddress>Victoria St Darlinghurst, NSW, 2010</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC</fundingname>
      <fundingaddress>National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Observations from previous studies suggest that testosterone acts on liver to induce protein anabolic effect. We will test the hypothesis that testosterone by acting on the liver, preserves protein loss in healthy men. </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Western Sydney Local Health District HREC</ethicname>
      <ethicaddress>WSLHD, Westmead Hospital, 
	Darcy Rd
Westmead, NSW 2145</ethicaddress>
      <ethicapprovaldate>11/09/2014</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Vita Birzniece</name>
      <address>UWS Clinical School and Research Centre
Blacktown Hospital,
18 Blacktown Rd
Blacktown, NSW 2148</address>
      <phone>+61 2 98516059</phone>
      <fax />
      <email>v.birzniece@uws.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Vita Birzniece</name>
      <address>UWS Clinical School and Research Centre
Blacktown Hospital
18 Blacktown Rd
Blacktown, NSW 2148</address>
      <phone>+61 2 98516059</phone>
      <fax />
      <email>v.birzniece@uws.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Vita Birzniece</name>
      <address>UWS Clinical School and Research Centre
Blacktown Hospital
18 Blacktown Rd
Blacktown, NSW 2148</address>
      <phone>+61 2 98516059</phone>
      <fax />
      <email>v.birzniece@uws.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Vita Birzniece</name>
      <address>UWS Clinical School and Research Centre
Blacktown Hospital
Blacktown, NSW 2148</address>
      <phone />
      <fax />
      <email>v.birzniece@uws.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>